[1]
“Probable Reversible Encephalopathy with Ceftazidime/Avibactam and Aztreonam: A Case Report”, AJPHS, vol. 16, no. 2, pp. 3283–3287, Jun. 2026, doi: 10.5530/ajphs.2026.16.94.